Skip to main content

Table 6 Skeletal and dental treatment effects in the Mentoplate group

From: Early Class III treatment with Hybrid-Hyrax -Facemask in comparison to Hybrid-Hyrax-Mentoplate – skeletal and dental outcomes

Variables Mentoplate T0 Mentoplate T1 p values CI 95%  
SNA° 79.23 ± 3.08 81.47 ± 3.15 0.000* 1.49 2.97
SNB° 80.09 ± 3.05 79.79 ± 3.20 0.070 − 0.42 0.97
ANB° − 0.86 ± 1.83 1.68 ± 1.55 0.000* 2.20 3.20
WITS mm − 5.83 ± 1.35 − 1.69 ± 1.32 0.000* 3.74 5.05
ATV mm 59.42 ± 4.97 62.09 ± 5.03 0.000* 1.90 3.44
BTV mm 58.24 ± 7.04 58.50 ± 7.24 0.973 − 0.91 0.88
ABTV mm 1.18 ± 2.88 3.59 ± 2.91 0.000* 2.16 3.17
ML-NL° 27.87 ± 6.18 27.97 ± 6.05 0.869 − 1.26 1.07
ML-NSL° 34.95 ± 6.94 34.40 ± 6.87 0.055 − 0.01 1.11
NSL-NL° 7.08 ± 3.74 6.44 ± 3.56 0.229 − 0.44 1.73
AR-GO-ME° 128.10 ± 4.99 125.14 ± 8.36 0.000* − 3.96 − 1.94
MOK-A mm 26.43 ± 1.93 26.32 ± 1.86 0.054 0.00 0.22
U1-PP° 110.36 ± 6.79 110.78 ± 5.12 0.752 − 3.22 2.37
L1-ML° 86.52 ± 6.93 85.97 ± 6.22 0.556 − 1.41 2.52
  1. *significant at p < 0.05